Karen Schumacher
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Karen Schumacher has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Debora L. Oh
Department of Epidemiology and Biostatistics, University of California, San Francisco, 550 16th St., Floor 2, San Francisco, CA, 94143, United States, 1 415-476-2300
7 shared publications - Katarina Wang
Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California
7 shared publications - Katherine Lin
Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California
7 shared publications - Salma Shariff-Marco
Department of Epidemiology and Biostatistics, University of California , San Francisco, CA
7 shared publications - Scarlett Lin Gomez
Department of Epidemiology and Biostatistics University of California San Francisco San Francisco California USA
7 shared publications - Debbie Goldberg
University of California, San Francisco 1 Department of Epidemiology and Biostatistics, School of Medicine San Francisco, California
6 shared publications
Latest Publications
- Open Access
- 1 November 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table 3 from Disparities in Cancer Stage of Diagnosis by Rurality in California, 2015 to 2019
OR for late stage diagnosis, non-Hispanic White
- 1 November 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 3 from Disparities in Cancer Stage of Diagnosis by Rurality in California, 2015 to 2019
OR for late stage diagnosis, non-Hispanic White
- Open Access
- 1 November 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table 2 from Disparities in Cancer Stage of Diagnosis by Rurality in California, 2015 to 2019
OR for late stage diagnosis, overall
- 1 November 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 2 from Disparities in Cancer Stage of Diagnosis by Rurality in California, 2015 to 2019
OR for late stage diagnosis, overall
- Open Access
- 1 November 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table 1 from Disparities in Cancer Stage of Diagnosis by Rurality in California, 2015 to 2019
Supplementary Table 1 shows covariables included in sequential models
- 1 November 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 1 from Disparities in Cancer Stage of Diagnosis by Rurality in California, 2015 to 2019
Supplementary Table 1 shows covariables included in sequential models
- Open Access
- 1 November 2024
- Published by American Association for Cancer Research (AACR)
Data from Disparities in Cancer Stage of Diagnosis by Rurality in California, 2015 to 2019
Background:Cancer rates in rural areas vary by insurance status, socioeconomic status, region, race, and ethnicity.Methods:California Cancer Registry data (2015–2019) were used to investigate the stage of diagnosis by levels of rurality for the five most common cancers. The percentage of residents in rural blocks within census tract aggregation zones was categorized into deciles up to 50%. Multivariable logistic regression was used to estimate associations with rurality, with separate models by cancer site, sex, race, and ethnicity (non-Hispanic White and Hispanic). Covariates included individual-level and zone-level factors.Results:The percentage of late-stage cancer diagnosis was 28% for female breast, 27% for male prostate, 77% for male lung, 71% for female lung, 60% for male colorectal, 59% for female colorectal, 7.8% for male melanoma, and 5.9% for female melanoma. Increasing rurality was significantly associated with increased odds of late-stage cancer diagnosis for female breast cancer (Ptrend < 0.001), male lung cancer (Ptrend < 0.001), female lung cancer (Ptrend < 0.001), and male melanoma (Ptrend = 0.01), after adjusting for individual-level and zone-level factors. The strength of associations varied by sex and ethnicity. For males with lung cancer, odds of late-stage diagnosis in areas with >50% rural population was 1.24 (95% confidence interval, 1.06–1.45) for non-Hispanic White patients and 2.14 (95% confidence interval, 0.86–5.31) for Hispanic patients, compared with areas with 0% rural residents.Conclusions:Increasing rurality was associated with increased odds for late-stage diagnosis for breast cancer, lung cancer, and melanoma, with the strength of associations varying across sex and ethnicity.Impact:Our findings will inform cancer outreach to these rural subpopulations.
- 1 November 2024
- Published by American Association for Cancer Research (AACR)
Open AccessData from Disparities in Cancer Stage of Diagnosis by Rurality in California, 2015 to 2019
Background:Cancer rates in rural areas vary by insurance status, socioeconomic status, region, race, and ethnicity.Methods:California Cancer Registry data (2015–2019) were used to investigate the stage of diagnosis by levels of rurality for the five most common cancers. The percentage of residents in rural blocks within census tract aggregation zones was categorized into deciles up to 50%. Multivariable logistic regression was used to estimate associations with rurality, with separate models by cancer site, sex, race, and ethnicity (non-Hispanic White and Hispanic). Covariates included individual-level and zone-level factors.Results:The percentage of late-stage cancer diagnosis was 28% for female breast, 27% for male prostate, 77% for male lung, 71% for female lung, 60% for male colorectal, 59% for female colorectal, 7.8% for male melanoma, and 5.9% for female melanoma. Increasing rurality was significantly associated with increased odds of late-stage cancer diagnosis for female breast cancer (Ptrend < 0.001), male lung cancer (Ptrend < 0.001), female lung cancer (Ptrend < 0.001), and male melanoma (Ptrend = 0.01), after adjusting for individual-level and zone-level factors. The strength of associations varied by sex and ethnicity. For males with lung cancer, odds of late-stage diagnosis in areas with >50% rural population was 1.24 (95% confidence interval, 1.06–1.45) for non-Hispanic White patients and 2.14 (95% confidence interval, 0.86–5.31) for Hispanic patients, compared with areas with 0% rural residents.Conclusions:Increasing rurality was associated with increased odds for late-stage diagnosis for breast cancer, lung cancer, and melanoma, with the strength of associations varying across sex and ethnicity.Impact:Our findings will inform cancer outreach to these rural subpopulations.
- Open Access
- 1 November 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table 4 from Disparities in Cancer Stage of Diagnosis by Rurality in California, 2015 to 2019
OR for late stage diagnosis, Hispanic
- 1 November 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 4 from Disparities in Cancer Stage of Diagnosis by Rurality in California, 2015 to 2019
OR for late stage diagnosis, Hispanic
- 14 August 2024
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 33 (11) , 1523-1531
Disparities in Cancer Stage of Diagnosis by Rurality in California, 2015 to 2019
Background: Cancer rates in rural areas vary by insurance status, socioeconomic status, region, race, and ethnicity. Methods: California Cancer Registry data (2015–2019) were used to investigate the stage of diagnosis by levels of rurality for the five most common cancers. The percentage of residents in rural blocks within census tract aggregation zones was categorized into deciles up to 50%. Multivariable logistic regression was used to estimate associations with rurality, with separate models by cancer site, sex, race, and ethnicity (non-Hispanic White and Hispanic). Covariates included individual-level and zone-level factors. Results: The percentage of late-stage cancer diagnosis was 28% for female breast, 27% for male prostate, 77% for male lung, 71% for female lung, 60% for male colorectal, 59% for female colorectal, 7.8% for male melanoma, and 5.9% for female melanoma. Increasing rurality was significantly associated with increased odds of late-stage cancer diagnosis for female breast cancer (Ptrend < 0.001), male lung cancer (Ptrend < 0.001), female lung cancer (Ptrend < 0.001), and male melanoma (Ptrend = 0.01), after adjusting for individual-level and zone-level factors. The strength of associations varied by sex and ethnicity. For males with lung cancer, odds of late-stage diagnosis in areas with >50% rural population was 1.24 (95% confidence interval, 1.06–1.45) for non-Hispanic White patients and 2.14 (95% confidence interval, 0.86–5.31) for Hispanic patients, compared with areas with 0% rural residents. Conclusions: Increasing rurality was associated with increased odds for late-stage diagnosis for breast cancer, lung cancer, and melanoma, with the strength of associations varying across sex and ethnicity. Impact: Our findings will inform cancer outreach to these rural subpopulations.
- 14 August 2024
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 33 (11) , 1523-1531
Disparities in Cancer Stage of Diagnosis by Rurality in California, 2015 to 2019
Background: Cancer rates in rural areas vary by insurance status, socioeconomic status, region, race, and ethnicity. Methods: California Cancer Registry data (2015–2019) were used to investigate the stage of diagnosis by levels of rurality for the five most common cancers. The percentage of residents in rural blocks within census tract aggregation zones was categorized into deciles up to 50%. Multivariable logistic regression was used to estimate associations with rurality, with separate models by cancer site, sex, race, and ethnicity (non-Hispanic White and Hispanic). Covariates included individual-level and zone-level factors. Results: The percentage of late-stage cancer diagnosis was 28% for female breast, 27% for male prostate, 77% for male lung, 71% for female lung, 60% for male colorectal, 59% for female colorectal, 7.8% for male melanoma, and 5.9% for female melanoma. Increasing rurality was significantly associated with increased odds of late-stage cancer diagnosis for female breast cancer (Ptrend < 0.001), male lung cancer (Ptrend < 0.001), female lung cancer (Ptrend < 0.001), and male melanoma (Ptrend = 0.01), after adjusting for individual-level and zone-level factors. The strength of associations varied by sex and ethnicity. For males with lung cancer, odds of late-stage diagnosis in areas with >50% rural population was 1.24 (95% confidence interval, 1.06–1.45) for non-Hispanic White patients and 2.14 (95% confidence interval, 0.86–5.31) for Hispanic patients, compared with areas with 0% rural residents. Conclusions: Increasing rurality was associated with increased odds for late-stage diagnosis for breast cancer, lung cancer, and melanoma, with the strength of associations varying across sex and ethnicity. Impact: Our findings will inform cancer outreach to these rural subpopulations.
- 9 January 2023
- Published by Oxford University Press (OUP) in JNCI: Journal of the National Cancer Institute
- Vol. 115 (4) , 385-393
Disparities in cancer incidence by rurality in California
Background: Cancer rates in rural areas across the United States have different patterns than in urban areas. This study examines associations between rurality and incidence for the top 5 cancers in California and evaluates whether these associations vary jointly by sex, race, and ethnicity. Methods: We used 2015-2019 California Cancer Registry data to compare incidence rate ratios (IRRs) and trends for breast, prostate, lung, colorectal, and skin (melanoma) cancers. We leveraged census tract aggregation zones and 7 levels of percentage rural population (0%, >0% to <10%, 10% to <20%, 20% to <30%, 30% to <40%, 40% to <50%, and 50+%). Results: Zones with higher proportions of rural population were significantly associated with lower incidence of female breast cancer and prostate cancer, though the trends were not statistically significant overall. Zones with higher proportions of rural population were significantly associated with higher incidence of lung cancer and melanoma. There were no statistically significant trends for colorectal cancer overall. Comparing areas with 50% and over rural population with areas with 0% rural population, the IRR for lung cancer in Hispanic females was higher (IRR = 1.43, 95% confidence interval [CI] = 1.17 to 1.74) than in Hispanic males (IRR = 0.90, 95% CI = 0.72 to 1.11). Also, in areas with 50% or more rural population, the IRR for melanoma was higher in Hispanic females (IRR = 1.75, 95% CI = 1.23 to 2.45) than non-Hispanic White females (IRR = 0.87, 95% CI = 0.80 to 0.95). Conclusions: Our findings show that rurality is associated with cancer incidence and underscore the importance of jointly examining rural disparities with sex, race, and ethnicity by cancer site.
- 9 January 2023
- Published by Oxford University Press (OUP) in JNCI: Journal of the National Cancer Institute
- Vol. 115 (4) , 385-393
Disparities in cancer incidence by rurality in California
Background: Cancer rates in rural areas across the United States have different patterns than in urban areas. This study examines associations between rurality and incidence for the top 5 cancers in California and evaluates whether these associations vary jointly by sex, race, and ethnicity. Methods: We used 2015-2019 California Cancer Registry data to compare incidence rate ratios (IRRs) and trends for breast, prostate, lung, colorectal, and skin (melanoma) cancers. We leveraged census tract aggregation zones and 7 levels of percentage rural population (0%, >0% to <10%, 10% to <20%, 20% to <30%, 30% to <40%, 40% to <50%, and 50+%). Results: Zones with higher proportions of rural population were significantly associated with lower incidence of female breast cancer and prostate cancer, though the trends were not statistically significant overall. Zones with higher proportions of rural population were significantly associated with higher incidence of lung cancer and melanoma. There were no statistically significant trends for colorectal cancer overall. Comparing areas with 50% and over rural population with areas with 0% rural population, the IRR for lung cancer in Hispanic females was higher (IRR = 1.43, 95% confidence interval [CI] = 1.17 to 1.74) than in Hispanic males (IRR = 0.90, 95% CI = 0.72 to 1.11). Also, in areas with 50% or more rural population, the IRR for melanoma was higher in Hispanic females (IRR = 1.75, 95% CI = 1.23 to 2.45) than non-Hispanic White females (IRR = 0.87, 95% CI = 0.80 to 0.95). Conclusions: Our findings show that rurality is associated with cancer incidence and underscore the importance of jointly examining rural disparities with sex, race, and ethnicity by cancer site.
- 6 April 2021
- Published by Wiley in Research in Nursing & Health
- Vol. 44 (3) , 571-580
Methodological considerations for the design and implementation of a fully longitudinal mixed methods study
Growing interest is evident in longitudinal mixed methods research, particularly fully longitudinal mixed methods designs in which both quantitative and qualitative data are collected concurrently for the duration of the study. Fully longitudinal mixed methods designs are particularly relevant for research on dynamic phenomena because of their ability to illuminate both quantitative and qualitative dimensions of change in real time as the phenomenon of interest changes. However, these are complex research designs and their data‐intense nature makes them potentially burdensome for study participants, challenging for research teams, and costly for funding agencies. Despite growing use, the methodological literature on fully longitudinal mixed methods research is sparse and little guidance is available for researchers considering this approach. We address this gap by describing our experience with the design and implementation of a fully longitudinal mixed methods study of a dynamic phenomenon, namely, family caregiving during cancer treatment. We describe important questions and key decisions confronted while developing the research proposal, proactive strategies for study implementation, and implementation realities encountered while the study was in progress. On the basis of insights gained through real‐world experience, we offer three guiding principles for researchers undertaking such a study. First, align the study design with the nature of the dynamics in the phenomenon of interest. Second, plan from the start when and how the integration of the longitudinal quantitative and qualitative data will occur. Third, employ implementation strategies that take into account the practical aspects of repeated contacts with study participants for an extended period.
- 6 April 2021
- Published by Wiley in Research in Nursing & Health
- Vol. 44 (3) , 571-580
Methodological considerations for the design and implementation of a fully longitudinal mixed methods study
Growing interest is evident in longitudinal mixed methods research, particularly fully longitudinal mixed methods designs in which both quantitative and qualitative data are collected concurrently for the duration of the study. Fully longitudinal mixed methods designs are particularly relevant for research on dynamic phenomena because of their ability to illuminate both quantitative and qualitative dimensions of change in real time as the phenomenon of interest changes. However, these are complex research designs and their data‐intense nature makes them potentially burdensome for study participants, challenging for research teams, and costly for funding agencies. Despite growing use, the methodological literature on fully longitudinal mixed methods research is sparse and little guidance is available for researchers considering this approach. We address this gap by describing our experience with the design and implementation of a fully longitudinal mixed methods study of a dynamic phenomenon, namely, family caregiving during cancer treatment. We describe important questions and key decisions confronted while developing the research proposal, proactive strategies for study implementation, and implementation realities encountered while the study was in progress. On the basis of insights gained through real‐world experience, we offer three guiding principles for researchers undertaking such a study. First, align the study design with the nature of the dynamics in the phenomenon of interest. Second, plan from the start when and how the integration of the longitudinal quantitative and qualitative data will occur. Third, employ implementation strategies that take into account the practical aspects of repeated contacts with study participants for an extended period.
- 1 March 2021
- Published by Wolters Kluwer Health in Cancer Nursing
- Vol. 44 (2) , 136-144
The Experience of Complex Pain Dynamics in Oncology Outpatients
Background: Few qualitative studies of cancer patients’ everyday experiences with pain exist within the large body of cancer pain research. Longitudinal qualitative studies are particularly sparse, and no studies have qualitatively described patients’ pain experience over time during participation in a self-management intervention. Objective: To longitudinally describe patients’ pain experiences during a 10-week pain self-management intervention. Methods: This qualitative study was embedded in a randomized controlled trial of a psychoeducational pain management intervention. The data consisted of transcribed audio recordings of each intervention session. An emergent, interpretive approach was used in this longitudinal qualitative analysis. Results: Forty-two adult patients were included. The analysis revealed the strikingly dynamic nature of individual patient’s pain experiences. Multiple facets of pain contributed to its dynamic nature, including pain in changing locations, co-occurring sources of pain, and varying patterns of pain intensity over time. For individual patients, the cumulative effect of these multiple facets resulted in a phenomenon we termed “complex pain dynamics.” Conclusion: The results contribute to knowledge about the dynamic nature of cancer patients’ pain experiences over a relatively short period. They suggest the need for a new paradigm for management of pain in cancer patients and raise questions about the interpretation of randomized controlled trial results in the absence of qualitative data. Implications for Practice: Frequent assessments and reassessments of pain are needed in cancer patients with the ongoing development of highly individualized self-management strategies. A large repertoire of interventions is needed to effectively manage pain in cancer patients over time.
- 1 March 2021
- Published by Wolters Kluwer Health in Cancer Nursing
- Vol. 44 (2) , 136-144
The Experience of Complex Pain Dynamics in Oncology Outpatients
Background: Few qualitative studies of cancer patients’ everyday experiences with pain exist within the large body of cancer pain research. Longitudinal qualitative studies are particularly sparse, and no studies have qualitatively described patients’ pain experience over time during participation in a self-management intervention. Objective: To longitudinally describe patients’ pain experiences during a 10-week pain self-management intervention. Methods: This qualitative study was embedded in a randomized controlled trial of a psychoeducational pain management intervention. The data consisted of transcribed audio recordings of each intervention session. An emergent, interpretive approach was used in this longitudinal qualitative analysis. Results: Forty-two adult patients were included. The analysis revealed the strikingly dynamic nature of individual patient’s pain experiences. Multiple facets of pain contributed to its dynamic nature, including pain in changing locations, co-occurring sources of pain, and varying patterns of pain intensity over time. For individual patients, the cumulative effect of these multiple facets resulted in a phenomenon we termed “complex pain dynamics.” Conclusion: The results contribute to knowledge about the dynamic nature of cancer patients’ pain experiences over a relatively short period. They suggest the need for a new paradigm for management of pain in cancer patients and raise questions about the interpretation of randomized controlled trial results in the absence of qualitative data. Implications for Practice: Frequent assessments and reassessments of pain are needed in cancer patients with the ongoing development of highly individualized self-management strategies. A large repertoire of interventions is needed to effectively manage pain in cancer patients over time.
- 1 August 2020
- Published by Elsevier in European Journal of Oncology Nursing
- Vol. 47, 101751
Initial psychometric testing of the Head and Neck Cancer Patient Self-Management Inventory (HNC-PSMI)
- 1 August 2020
- Published by Elsevier in European Journal of Oncology Nursing
- Vol. 47, 101751
Initial psychometric testing of the Head and Neck Cancer Patient Self-Management Inventory (HNC-PSMI)